Molecular design of LPS-binding peptides

Area of Science:

• Microbiology
• Biochemistry
• Peptide Chemistry

Background:

• Lipopolysaccharide (LPS) from Gram-negative bacteria is a potent endotoxin causing sepsis and septic shock.
• Effective detection and neutralization of LPS are crucial for managing severe infections.
• Previous work identified the LPS-binding peptide Li5-001 using phage display.

Purpose of the Study:

• To enhance the LPS-binding affinity and protease resistance of the Li5-001 peptide.
• To develop a more potent therapeutic agent for LPS neutralization.

Main Methods:

• Peptide sequence modification of Li5-001 through amino acid replacement and deletion.
• Incorporation of D-amino acids at the N- and C-termini to increase protease resistance.
• Affinity determination using Kd values, comparing the modified peptide to the original.

Main Results:

• A novel dodecapeptide, Li5-025, was synthesized with significantly improved LPS-binding affinity (Kd = 0.01 nM, ~1000-fold increase over Li5-001).
• The D-amino acid substitution rendered Li5-025 resistant to protease digestion without compromising binding.
• The modified peptide demonstrated enhanced stability and binding capacity.

Conclusions:

• The dodecapeptide Li5-025 represents a significant advancement in LPS-binding peptides.
• Its high affinity and protease resistance make it a promising candidate for developing novel therapeutics against LPS-induced toxicity.
• Further research may explore its in vivo efficacy for sepsis treatment.